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Background: Epidemiological and clinical studies have largely demonstrated major differences in the prevalence of metabolic disorders in males
and females, but the biological cause of these dissimilarities remain to be elucidated. Mammals are characterized by a major change in
reproductive strategies and it is conceivable that these changes subjected females to a signiﬁcant evolutionary pressure that perfected the
coupling between energy metabolism and reproduction.
Scope of review: This review will address the plausibility that female liver functions diverged signiﬁcantly from males given the role of liver in the
control of metabolism. Indeed, it is well known that the liver is sexually dimorphic, and this might be relevant to explain the lower susceptibility to
hepatic diseases and liver-derived metabolic disturbances (such as the cardiovascular diseases) characteristic of females during their fertile
period. Furthermore, estrogens and the hepatic ERa play a signiﬁcant role in liver sexual-speciﬁc functions and in the control of metabolic
functions.
Conclusions: A better grasp of the role of male and female sex steroids in the liver of the two sexes may therefore represent an important
element to conceive novel treatments aimed at preventing metabolic diseases particularly in ageing women or limiting undesired side effect in the
treatment of gender dysphoria.
 2018 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords Sex; Health1. SHINING LIGHT ON THE ACTION OF ESTROGENS
Among sex steroid hormones, estrogens distinguish themselves for
the variety of their target tissues. Indeed, in mammals, receptors for
estrogens are present in most cells, thus enabling these hormones
to regulate or interfere with a signiﬁcant number of metabolic
pathways. Presently, we know two isoforms of estrogen receptors
(ERa and ERb) that are present in mammals and share with the
other members of the nuclear receptors (NRs) family a well
conserved structural organization and mode of action [1,2]. These
intracellular receptors are ligand-operated transcription factors that,
in addition to their genomic actions, may interact with other cyto-
plasmic second messengers and nuclear proteins modulating their
activities. To regulate the transcription of their target genes, ERs
need to be “activated” by the cognate ligand or post-translational
modiﬁcations (unliganded activation) that induce a rearrangement
of the receptor structure resulting in the release of the inhibitory
proteins and exposure of the receptor sequences able to recognize
the “estrogen responsive elements” in the proximity of the estrogen-
responsive genes [3]. Upon binding the EREs, the ERs need to
interact with co-regulator proteins in order to induce or repress
target gene transcription [4]. Besides enabling ERs to interact with
the transcription machinery, the interaction with the co-regulators
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was underlined by the study of the effects of estrogenic compounds
such a tamoxifen, Raloxifene, and others that, upon binding, were
shown to induce an ER conformation able to interact with a subclass
of co-regulators and therefore provide the receptor protein with a
shade of activities ranging from partial agonist to antagonist in
dependence of the tissue of action [5].
Considering the mechanism of intracellular ER action, cell response to
estrogens generally occurs in the frame of hours; more recently, it was
found that ERa may be palmitoylated and translocate to the cell
membrane and transmit the hormonal signal by regulating G protein
signaling [2]; it is plausible that this alternative type of regulation oc-
curs in a shorter length of time (minutes). However, estrogens were
reported also to induce very rapid effect (timeframe of a second or
less); these were found to be mediated by a bona ﬁde, membrane, G
protein-coupled receptor named GPER30 [6].
Thus, estrogens may control the activities of target cells in an
extremely diversiﬁed manner enabling these receptors to elicit re-
sponses extremely differentiated from cell to cell or, in the same cells,
from time to time.
The molecular mechanism of estrogen action has been mostly studied
in cell models; to acquire a better view on the exact ER targets and the
timing of the response to estrogens in living animals, we generated a
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Reviewreporter gene driven by an estrogen-responsive promoter. The reporter
cassette was conceived to prevent position effects due to the site of
integration and, the strict dependency of luciferase transcription by the
activated ERs was fully demonstrated [7]. This mouse line, named
ERE-Luc, by enabling the systematic, spatio-temporal analysis of es-
trogen action highlighted, for the ﬁrst time, the liver is a major targets
of estrogen action and pointed to a potential role for ER in connecting
metabolic and reproductive functions [8e10]. These initial ﬁndings
were later on conﬁrmed in other laboratories [11].
2. THE INDISSOLUBLE BOND BETWEEN REPRODUCTIVE AND
METABOLIC FUNCTIONS
In biology, reproduction is the key function to guarantee immortality
and adaptability to living organisms. However, in an environment poor
in nutrients (that characterized the evolution of current living species),
an uncontrolled rate of fertility might lead to extinction. It is imaginable,
therefore, that mechanisms associating reproductive functions to en-
ergy availability were established in the course of evolution; the mo-
lecular details of such reciprocal interaction were shown in insects and
nematodes, but very little is known with regard this potential mutual
interaction in mammals.
As mentioned, studies in the ERE-Luc mouse revealed that estrogens
were very active in the liver, the metabolic organ par excellence. The
study of the distribution of ERs in the course of phylogenesis indicated
that since their appearance in the animal world (in the vertebrate
Agnatha) the two organs where ERs were most expressed have been
the gonads and the liver (or liver ancestor organs, like the hepato-
pancreas in crustaceans). This is not surprising, because, in egg laying
animals, the liver is known to have a major role in the control of
reproductive functions as it is primarily responsible for the synthesis of
yolk proteins (vitellogenins) to the ovaries [12]. In all vertebrates, the
gonadal 17b-estradiol tightly regulates such a synthesis to prevent
dissipation of energies towards the synthesis of proteins not imme-
diately required. This may explain why in all oviparous the high
expression of ERs in the gonads and liver is so well conserved [10,13].
In mammals, severe malnutrition and allostatic overload reduces
fertility [13,14]; considering that the mammalian egg does not require
storage all the energy molecules, a characteristic of egg laying spe-
cies, the question raised is whether in mammals the liver maintains its
key role for the control of reproduction and to what extent the hepatic
estrogen receptor is involved in this function. Actually, several lines of
experimental evidence showed that the hepatic ERs participate in the
control of the mammalian ovulatory cycle through the regulation of the
synthesis of IGF-1 and VLDL, both necessary for a productive repro-
ductive cycle [14,15]. Quite interesting is the fact that, at least in mice,
the transcriptional activity of the hepatic ERa is under the dual control
of estrogens and amino acids (AA) provided by the diet [16]. More
precisely, the hepatic ERa transcriptional activity is mitigated by the
lack of nutritional proteins [15], and, in the event of prolonged calorie
restriction, gonadal estrogens are unable to fully activate the liver ERa
and the IGF-1 and lipoproteins are no longer synthesized to the extent
necessary for a successful ovulation [14]. This demonstrates that, also
in mammals, nutritional signaling is relevant for fertility and that the
hepatic ERs maintain the role selected by evolution consisting in its
ability to regulate fertility in relation to nutrient availability. However, in
spite of the major role played by the liver ERa, the fact that mice with
the selective deletion of liver ERa are fertile suggests that, in mam-
mals, this is not the only element controlling liver functions, and other
endocrine factors must have acquired a role that need to be
investigated.4 MOLECULAR METABOLISM 15 (2018) 3e7  2018 Published by Elsevier GmbH. This is3. THE REPRODUCTIVE STATUS AND METABOLISM IN
MAMMALS
Thus, in mammals, the liver ERa maintains the role of a sensor of
gonadal and nutritional cues necessary to couple fertility to the envi-
ronmental conditions. However, the growth of the mammalian embryo
in the mother’s womb and the lactation requirement necessary for
sustaining the offspring imposed a novel toll on energy metabolism
that required a signiﬁcant adaptation to guarantee the scrupulous use
of the scarce nutrients available. As a sensor of reproductive and
metabolic cues it is conceivable that the liver and hepatic ERa took
over this responsibility and mechanisms were created to adjust liver
ability to generate energy to the changing needs of female reproductive
apparatus.
We now know that in the initial phases of pregnancy, the liver adjusts
lipoprotein and cholesterol synthesis to provide the placenta with the
necessary supply of precursors for steroidogenesis and membrane
synthesis; in the meantime, this organ facilitates lipid transport to the
adipose tissue where these molecules are stocked in large amounts to
ensure the appropriate energy supply all through pregnancy [17,18].
Later on, liver metabolism contributes to the increased energy de-
mands from the placenta feeding the growing embryo by enhancing
glucose output (by 16e30%) while gluconeogenesis is reduced to
maintain high levels of the amino acids (AA) necessary to the ﬁnal
phases of the fetus growth [19,20]. After birth, the drop of circulating
estrogens promotes triglyceride synthesis, and the metabolic role of
liver is driven by the needs of the mammary gland with high glucose
production obtained; in this phase, b-oxidation has a predominant role
for the production of the ATP required by gluconeogenesis [21,22].
Thus, the liver is clearly playing a key role in diverting energy resources
to meet the needs of reproduction, but the endocrine signals directing
liver functions and the mechanisms involved remain to be understood.
There is no doubt that estrogens and their hepatic receptors are very
relevant for the control of liver functions. It is well known that after
menopause and the cessation of estrogen synthesis by the ovaries, the
incidence of non-alcoholic fatty liver diseases (NAFLD) increases
signiﬁcantly in women, and hormone replacement therapy reduces
hepatic steatosis risk and NAFLD prevalence [24e26]. Indeed, in
experimental animals, ovariectomy or liver selective ablation of the
estrogen receptor is associated with increased lipid synthesis and fat
deposition in the liver substantiating the clinical studies [14,27], even if
the use of different selective mutants of the ER showed that ERa-
mediated direct transcription in non-hepatic tissues contributes to
estrogen-mediated protection against hepatic steatosis (particularly in
high fat diet-fed females) [28]. Other alterations of ovarian functions
are associated with NAFLD and metabolic disturbances. For instance,
individuals with polycystic ovarian syndrome (PCOS) that is charac-
terized by chronic anovulation have dyslipidemia and are overweight or
obese [23,29]. Several of them develop insulin resistance (IR),
impaired glucose tolerance, and type 2 diabetes mellitus (T2DM). As a
result, these patients are treated with the insulin sensitized metformin.
However, recent clinical studies have shown that combined oral
contraceptives plus spironolactone are more effective than metformin
for symptoms of PCOS [30], suggesting that alterations in the sex
hormone production by the ovaries is the predominant element in the
PCOS etiology. Estrogen therapy has important beneﬁcial effects also
on the metabolic alterations of Turner syndrome (TS), a genetic dis-
order caused by the partial or complete absence of one of the X
chromosomes in females. Women with TS are generally obese, have
low lean mass and high content of visceral adipose tissue, elevated
triglycerides, and high LDL/HDL ratio. Treatment of these patients withan open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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estrogens leads to decreased visceral adipose tissue, increased
circulating HDL, and an improvement of hepatic functions with regu-
lation of growth and anti-apoptotic growth factors that maintain the
integrity of hepatocytes and their capacity to proliferate [31,32].
4. LIVER SEXUAL DIMORPHISM, A CONSEQUENCE OF LIVER
ADAPTATION TO MAMMALIAN REPRODUCTIVE FUNCTIONS
All together, these observations suggest that in female mammals liver
and hepatic ERa were able to adapt to the increased requests of the
reproductive apparatus and acquired novel mechanisms enabling
hepatic cells to modify their metabolism in relation to the host’s
reproductive status. Male mammals were not subjected to such an
evolutionary pressure, thus, as a logic consequence, the female liver
diverged signiﬁcantly in its functions from the male liver. Indeed,
among all somatic organs, the liver shows the highest degree for
sexual dimorphism with 72% of the genes expressed in a sexually
differentiated manner (in other organs the degree of sex-dependent
variability ranges between 14 and 60%) [33,34]. Not surprisingly,
the major sex differences are related to lipid and steroid metabolic
pathways: in comparison to males of the same age, adult fertile fe-
males have higher rates of hepatic fatty acid uptake, esteriﬁcation and
VLDL-TG synthesis and release, and lower FA oxidation [35e38]. In
addition, the liver of cycling females has an energy partition strategy
safeguarding all energies available and stocking them in deposits; this
is clearly geared to protect reproduction because in case of food
deprivation during pregnancy these lipids could be mobilized providing
the necessary energy to the growing embryo. As an example, in case of
short-term fasting, the decision to maintain lipid synthesis using amino
acids as a source of fuel is the key discriminant for the hepatic
metabolism of male and female mice (Della Torre et al. Cell Meta-
bolism, under revision). Several animal models showed that females
are protected against lipid deposition in the liver, for instance aERKO
and aromatase null male mice have signiﬁcant lipid inﬁltration in liver
not observed in females [28,39,40]. However, in all these studies, the
exact role of the hepatic ERa remains to be clariﬁed [14,41,42]
In view of the major function of liver in mammalian physio-pathology,
a better understanding of the sex-speciﬁc mechanisms driving food
partitioning and xenobiotics metabolism is mandatory for the
comprehension of the molecular bases of a large number of meta-
bolic disorders and for the application of appropriate pharmacolog-
ical/hormonal interventions. It would be also important to understand
which are the determinants of liver sexual differentiation and when
during development this occurs. Sexual differentiation of the brain
occurs, depending on the animal species, at the end of pregnancy/
few days after birth. Several groups showed that around this time of
development male gonads are activated to synthesize testosterone;
this sex hormone, as such or locally converted into estrogens by the
presence of the enzyme aromatase, is responsible for the mascu-
linization of the brain circuits that after puberty will control the
gonadal activities and sexual behavior [43,44]. We do not know
whether such a mechanism is at the bases of liver sexual differ-
entiation. In mice, the liver expresses both estrogen and testosterone
receptors at the end of pregnancy and in the ﬁrst days of life; the
presence of aromatase, however, is still controversial. In humans,
aromatase overexpression in liver disease was ﬁrst reported in
ﬁbrolamellar hepatocellular carcinoma (HCC) cells, in hepatitis, and
HCC, but, in normal liver, aromatase was reported to be detected
only in fetal hepatocytes and not in neonatal to adult liver [45e49].
Thus, it is conceivable that the testosterone synthesized by the
embryo or neonate is responsible for epigenetic modiﬁcations thatMOLECULAR METABOLISM 15 (2018) 3e7  2018 Published by Elsevier GmbH. This is an open access a
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the other hand, it could be postulated that the liver is not sexually
differentiated at birth, but its metabolism is simply regulated by
endocrine and nervous outputs from the sexually differentiated brain.
Deafferentation studies indicated earlier on that brain efferent do not
have a role in liver sexual differentiation. Other studies showed that
the sex-dependent secretory pattern of growth hormone (GH) (more
pulsatile in males than in females) might be accountable for sex-
dependent liver functions of mice [50e52]. However, only a few
investigations were carried out by mimicking the release of GH with
the administration of exogenous GH to demonstrate the direct
involvement of this hormone in liver sexual-speciﬁc activities. These
studies showed, for instance, that the induction of MUP (Major
Urinary Proteins) mRNA requires the pulsatile release of GH typical of
males, and such a GH release inhibits the synthesis of steroid sulfate
cytochrome P-450 15 beta-hydroxylase largely present in female
liver, thus suggesting a role of this mechanism in liver sex-speciﬁc
activities [53,54]. Several other studies showing a correlation be-
tween pattern of GH secretion and liver sex-dependent protein
synthesis were carried out in mice defeminized by neonatal treat-
ment of pups with testosterone propionate. Such treatment is very
effective in changing toward the male phenotype GH pulsatile activity
[55], but it cannot be ruled out that, in addition, such a treatment
has a direct effect on liver inducing its sexual differentiation.
In conclusion, while it is currently believed that liver is a sexually
differentiated organ, uncertainties still exist on the mechanisms
responsible.
5. THE ISSUE OF LIVER DIFFERENTIATION AND FUNCTIONS IN
TRANSGENDER INDIVIDUALS
The full understanding of hepatic ERa in female liver functions might
be of major help for the understanding of the onset of most metabolic
and inﬂammatory disorders associated with estrogen deﬁciency, as
happens with menopause. It is in fact most likely that the loss of the
feed-back and feed-forward mechanisms of mutual control between
ovaries and the liver have as a consequence an alteration of lipid and
cholesterol metabolism, deposits of fat in the liver triggering a systemic
inﬂammatory response that is at the bases of most pathologies
associated with aging (atherosclerosis, diabetes, osteoporosis, and
neural disorders). By demonstrating that liver ERa has a major role in
the increased incidence of these disorders in the climacterium, we
could devise novel, safer, and more efﬁcacious HRTs envisaging the
use of livers elective estrogen receptor modulators. In addition, this
might help in the identiﬁcation of the mechanisms that provide fertile
women with selective health advantages towards men.
Most recently, several authors addressed the issue of safety in the
hormonal treatments related to gender dysphoria. Gender dysphoria is
the distress a person experiences as a result of the sex and gender
they were assigned at birth in the case when the assigned sex does
not match the person’s gender identity [56,57]. People who experi-
ence gender dysphoria require cross-sex hormones to induce sec-
ondary sexual characteristics of the desired sex. For females
transitioning to males, testosterone is the main hormonal agent used
to induce (virilization) [58]; for males transitioning to females, estro-
gens are used.
In recent meta-analyses of the data in the literature, testosterone use
was associated with to modest increase in BMI, hemoglobin/he-
matocrit, and LDL-cholesterol, and a decrease in HDL-cholesterol;
estrogen was associated with lower testosterone and alanine
aminotransferase levels [58,59]. In light of the relevant role of liverrticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 5
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could predict that the effect of virilization may be more associated
with health risks than the opposite. However, the studies so far
available are all carried out in young subjects where the long term
hormonal effects are most likely still clinically undetectable.
While several studies have so far focused on the role of liver in coupling
hepatic metabolism to reproduction in female mammals, very little is
known with regard to the role of male liver in male reproduction and on
the activity of sex steroid hormones in this organ. We know that in
mouse, ERa and androgen receptor (AR) are expressed in males, but
the content of ERa is signiﬁcantly lower than in females [12]; so far
very little is known on the role of these two receptors in the regulation
of energy metabolism and food partitioning in males. In this context, a
better understanding would be helpful in predicting the potential harm
of testosterone treatments. In addition, health status would be a pri-
ority for understanding the mechanism determining liver sex-speciﬁc
functions. In case of neonatal differentiation of the liver, it would be
important to understand to what extent the liver may have been
masculinized in a female who is transitioning to male, because, in
these individuals, the effect of testosterone treatment during adoles-
cence might have effect much different than those in subject in which
the liver has a “female phenotype.” Thus, along the effects of mental
health, medical, and surgical interventions on morbidity and mortality,
a major priority in transgender individuals would be to determine
health disparities and comorbid health conditions over the life span.
In conclusion, the understanding of liver ERa activities in female liver
opens new perspectives for the understanding of the sex-dependent
prevalence of several pathologies associated with aging and should
be of inspiration for further studies aimed in particular to identify
efﬁcacious treatments for metabolic disorders in both sexes.
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